740 related articles for article (PubMed ID: 31494391)
1. Trends in the Use of Adjuvant Chemotherapy for High-Grade Truncal and Extremity Soft Tissue Sarcomas.
Squires MH; Ethun CG; Suarez-Kelly LP; Yu PY; Hughes TM; Shelby RD; Tran TB; Poultsides G; Charlson J; Gamblin TC; Tseng J; Roggin KK; Chouliaras K; Votanopoulos K; Krasnick BA; Fields RC; Pollock RE; Grignol V; Cardona K; Howard JH
J Surg Res; 2020 Jan; 245():577-586. PubMed ID: 31494391
[TBL] [Abstract][Full Text] [Related]
2. Assessing the Role of Neoadjuvant Chemotherapy in Primary High-Risk Truncal/Extremity Soft Tissue Sarcomas: An Analysis of the Multi-institutional U.S. Sarcoma Collaborative.
Zaidi MY; Ethun CG; Tran TB; Poultsides G; Grignol VP; Howard JH; Bedi M; Mogal H; Tseng J; Roggin KK; Chouliaras K; Votanopoulos K; Krasnick B; Fields RC; Oskouei S; Reimer N; Monson D; Maithel SK; Cardona K
Ann Surg Oncol; 2019 Oct; 26(11):3542-3549. PubMed ID: 31342400
[TBL] [Abstract][Full Text] [Related]
3. Perioperative chemotherapy is not associated with improved survival in high-grade truncal sarcoma.
Yu PY; Beal EW; Hughes TM; Suarez-Kelly LP; Shelby RD; Ethun CG; Tran TB; Poultsides G; Charlson J; Gamblin TC; Tseng J; Roggin KK; Chouliaras K; Votanopoulos K; Krasnick BA; Fields RC; Pollock RE; Grignol V; Cardona K; Howard JH
J Surg Res; 2018 Nov; 231():248-256. PubMed ID: 30278937
[TBL] [Abstract][Full Text] [Related]
4. Recurrence and survival analysis of resected soft tissue sarcomas of pelvic retroperitoneal structures.
Doepker MP; Hanna KH; Thompson ZJ; Binitie OT; Letson DG; Gonzalez RJ
J Surg Oncol; 2016 Jan; 113(1):103-7. PubMed ID: 26744131
[TBL] [Abstract][Full Text] [Related]
5. Impact of resection margin on outcomes in high-grade soft tissue sarcomas of the extremity-A USSC analysis.
Chouliaras K; Patel N; Senehi R; Ethun CG; Poultsides G; Grignol V; Gamblin TC; Roggin KK; Fields RC; D'Agostino R; Levine EA; Cardona K; Votanopoulos K
J Surg Oncol; 2021 Feb; 123(2):479-488. PubMed ID: 33150594
[TBL] [Abstract][Full Text] [Related]
6. Does the addition of chemotherapy to neoadjuvant radiotherapy impact survival in high-risk extremity/trunk soft-tissue sarcoma?
Chowdhary M; Chowdhary A; Sen N; Zaorsky NG; Patel KR; Wang D
Cancer; 2019 Nov; 125(21):3801-3809. PubMed ID: 31490546
[TBL] [Abstract][Full Text] [Related]
7. The Prognostic Value of Lymphovascular Invasion in Truncal and Extremity Soft Tissue Sarcomas: An Analysis from the National Cancer Database.
Ethun CG; Lopez-Aguiar AG; Switchenko JM; Gillespie TW; Delman KA; Staley CA; Maithel SK; Cardona K
Ann Surg Oncol; 2019 Dec; 26(13):4723-4729. PubMed ID: 31502023
[TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant chemoradiotherapy for patients with high-risk extremity and truncal sarcomas: a 10-year single institution retrospective study.
Look Hong NJ; Hornicek FJ; Harmon DC; Choy E; Chen YL; Yoon SS; Nielsen GP; Szymonifka J; Yeap BY; DeLaney TF; Mullen JT
Eur J Cancer; 2013 Mar; 49(4):875-83. PubMed ID: 23092789
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors in adolescents and young adults (AYA) with high risk soft tissue sarcoma (STS) treated by adjuvant chemotherapy: a study based on pooled European Organisation for Research and Treatment of Cancer (EORTC) clinical trials 62771 and 62931.
Kasper B; Ouali M; van Glabbeke M; Blay JY; Bramwell VH; Woll PJ; Hohenberger P; Schöffski P
Eur J Cancer; 2013 Jan; 49(2):449-56. PubMed ID: 22975215
[TBL] [Abstract][Full Text] [Related]
10. The impact of chemotherapy on survival of patients with extremity and trunk wall soft tissue sarcoma: revisiting the results of the EORTC-STBSG 62931 randomised trial.
Pasquali S; Pizzamiglio S; Touati N; Litiere S; Marreaud S; Kasper B; Gelderblom H; Stacchiotti S; Judson I; Dei Tos AP; Verderio P; Casali PG; Woll PJ; Gronchi A;
Eur J Cancer; 2019 Mar; 109():51-60. PubMed ID: 30690293
[TBL] [Abstract][Full Text] [Related]
11. Surveillance Imaging Patterns and Outcomes Following Radiation Therapy and Radical Resection for Localized Extremity and Trunk Soft Tissue Sarcoma.
Patel SA; Royce TJ; Barysauskas CM; Thornton KA; Raut CP; Baldini EH
Ann Surg Oncol; 2017 Jun; 24(6):1588-1595. PubMed ID: 28058559
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the 7th and 8th version of the AJCC classification system for soft tissue sarcomas of extremities and trunk in patients with localised, intermediate or high-grade disease treated at European tertiary sarcoma centres.
Smolle MA; van de Sande M; Hayes A; Bergovec M; Smith HG; Liegl-Atzwanger B; Tunn PU; Niethard M; Windhager R; Szkandera J; Leithner A
Eur J Surg Oncol; 2021 Aug; 47(8):2182-2188. PubMed ID: 33865657
[TBL] [Abstract][Full Text] [Related]
13. The prognostic significance of margin width for extremity and trunk sarcoma.
McKee MD; Liu DF; Brooks JJ; Gibbs JF; Driscoll DL; Kraybill WG
J Surg Oncol; 2004 Feb; 85(2):68-76. PubMed ID: 14755506
[TBL] [Abstract][Full Text] [Related]
14. Does adjuvant radiation therapy increase loco-regional control after optimal resection of soft-tissue sarcoma of the extremities?
Khanfir K; Alzieu L; Terrier P; Le Péchoux C; Bonvalot S; Vanel D; Le Cesne A
Eur J Cancer; 2003 Sep; 39(13):1872-80. PubMed ID: 12932665
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors predictive of survival for truncal and retroperitoneal soft-tissue sarcoma.
Singer S; Corson JM; Demetri GD; Healey EA; Marcus K; Eberlein TJ
Ann Surg; 1995 Feb; 221(2):185-95. PubMed ID: 7857146
[TBL] [Abstract][Full Text] [Related]
16. Histopathological tumor response following neoadjuvant hyperthermic isolated limb perfusion in extremity soft tissue sarcomas: Evaluation of the EORTC-STBSG response score.
Stevenson MG; Hoekstra HJ; Song W; Suurmeijer AJH; Been LB
Eur J Surg Oncol; 2018 Sep; 44(9):1406-1411. PubMed ID: 29858098
[TBL] [Abstract][Full Text] [Related]
17. The Impact of Perioperative Chemotherapy Timing in Conjunction With Postoperative External-Beam Radiation Therapy on Extremity Soft-Tissue Sarcomas Outcome.
Mahmoud O; Dosch A; Kwon D; Pitcher JD; Conway S; Benedetto P; Fernandez G; Trent J; Temple HT; Wolfson AH
Am J Clin Oncol; 2016 Oct; 39(5):528-34. PubMed ID: 24879472
[TBL] [Abstract][Full Text] [Related]
18. Doxorubicin-based adjuvant chemotherapy in soft tissue sarcoma: pooled analysis of two STBSG-EORTC phase III clinical trials.
Le Cesne A; Ouali M; Leahy MG; Santoro A; Hoekstra HJ; Hohenberger P; Van Coevorden F; Rutkowski P; Van Hoesel R; Verweij J; Bonvalot S; Steward WP; Gronchi A; Hogendoorn PCW; Litiere S; Marreaud S; Blay JY; Van Der Graaf WTA
Ann Oncol; 2014 Dec; 25(12):2425-2432. PubMed ID: 25294887
[TBL] [Abstract][Full Text] [Related]
19. Surgical Resection Margin Classifications for High-grade Pleomorphic Soft Tissue Sarcomas of the Extremity or Trunk After Neoadjuvant Cytotoxic Therapy.
Cates VM; Cates JMM
Am J Surg Pathol; 2019 Jun; 43(6):844-850. PubMed ID: 30932925
[TBL] [Abstract][Full Text] [Related]
20. Does Vacuum-assisted Closure Reduce the Risk of Wound Complications in Patients With Lower Extremity Sarcomas Treated With Preoperative Radiation?
Bedi M; King DM; DeVries J; Hackbarth DA; Neilson JC
Clin Orthop Relat Res; 2019 Apr; 477(4):768-774. PubMed ID: 30811365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
